| Aug 12 |
GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event
|
| Aug 12 |
Azenta Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 6 |
Azenta, Inc. (AZTA) Q3 2024 Earnings Call Transcript
|
| Aug 6 |
Azenta Non-GAAP EPS of $0.16 beats by $0.09, revenue of $173M beats by $7.35M
|
| Aug 6 |
Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024
|
| Jul 24 |
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
|
| Jul 22 |
FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study
|
| Jul 6 |
The past three years for Azenta (NASDAQ:AZTA) investors has not been profitable
|
| Jun 4 |
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
|
| May 23 |
Azenta to Participate in the Jefferies Global Healthcare Conference
|
